Abstract
Overexpression of vascular endothelial growth factor (VEGF) receptor promotes angiogenesis and vascular invasion in hepatocellular carcinoma (HCC). More strict patient selection for VEGF receptor targeted therapy based on evidence of micro vascular invasion may have prognostic benefit. In the present study, we aimed to investigate prognostic association between over expression of VEGF receptor and micro vascular invasion in patients with HCC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
